4//SEC Filing
Kane William 4
Accession 0001213900-20-030797
CIK 0001506251other
Filed
Oct 8, 8:00 PM ET
Accepted
Oct 9, 4:09 PM ET
Size
13.6 KB
Accession
0001213900-20-030797
Insider Transaction Report
Form 4
Kane William
Director
Transactions
- Award
Options to Purchase Common Stock
2020-10-06+35,000→ 35,000 totalExercise: $1.01Exp: 2030-10-06→ Common Stock (35,000 underlying)
Holdings
- 10,000
Options to Purchase Common Stock
Exercise: $3.45Exp: 2027-09-13→ Common Stock (10,000 underlying) - 13,334
Options to Purchase Common Stock
Exercise: $12.00Exp: 2026-06-23→ Common Stock (13,334 underlying) - 25,000
Options to Purchase Common Stock
Exercise: $0.67Exp: 2029-10-08→ Common Stock (25,000 underlying) - 25,000
Options to Purchase Common Stock
Exercise: $1.39Exp: 2030-07-07→ Common Stock (25,000 underlying) - 15,000
Options to Purchase Common Stock
Exercise: $1.62Exp: 2028-09-04→ Common Stock (15,000 underlying) - 12,071
Options to Purchase Common Stock
Exercise: $0.01Exp: 2024-03-28→ Common Stock (12,071 underlying)
Footnotes (7)
- [F1]The options vest in full on October 6, 2021.
- [F2]The options vest in full on July 7, 2021.
- [F3]The options vest in full on October 8, 2020.
- [F4]The options vest in full on September 4, 2019.
- [F5]The options vest in full on September 13, 2018.
- [F6]The options vested in 1/3 increments over a three-year period with the first installment vesting on March 28, 2015.
- [F7]The options vested in full on the first anniversary of the date of grant.
Documents
Issuer
Citius Pharmaceuticals, Inc.
CIK 0001506251
Entity typeother
Related Parties
1- filerCIK 0001671585
Filing Metadata
- Form type
- 4
- Filed
- Oct 8, 8:00 PM ET
- Accepted
- Oct 9, 4:09 PM ET
- Size
- 13.6 KB